NASDAQ: FOLDAmicus Therapeutics Inc Earnings Dates, Reports, Calls
*Your capital is at risk. Other fees apply.
Amicus Therapeutics earnings were -$29.4M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest FOLD earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$21.7M, down 247.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, FOLD reported annual earnings of -$56.1M, with -63% growth.
FOLD earnings history
Current Revenue
$543.1M
Current Earnings
-$29.4M
Current Profit Margin
-5.4%
FOLD Return on Equity
Current Company
-16.8%
Current Industry
-60.2%
Current Market
31.4%
FOLD's Return on Equity (-16.8%)... subscribe to Premium to read more.
High Return on Equity Performance
FOLD undefined
Current Company
-3.8%
Current Industry
-2.5%
FOLD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when FOLD announces earnings.
FOLD undefined
Current Company
7.13%
Current Industry
5.8%
FOLD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
FOLD vs Biotech Stocks
Amicus Therapeutics Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.